• 1
    Johannsson G, Rosén T, Bosaeus I, Sjöström L, Bengtsson BÅ. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1996; 81: 2865 73.
  • 2
    Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA. Growth hormone (GH) -deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 1997; 82: 550 55.
  • 3
    Verhelst J, Abs R, Vandeweghe M et al. Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol 1997; 47: 485 94.
  • 4
    Slootweg MC, Swolin D, Netelenbos JC, Isaksson OG, Ohlsson C. Estrogen enhances growth hormone receptor expression and growth hormone action in rat osteosarcoma cells and human osteoblast-like cells. J Endocrinol 1997; 155: 159 64.
  • 5
    Yeh JK, Chen MM, Aloia JF. Effects of estrogen and growth hormone on skeleton in the ovariectomized rat with hypophysectomy. Am J Physiol 1997; 273: 734 42.
  • 6
    Lopez-Guerra A, Chirino R, Navarro D et al. Estrogen antagonism on T3 and growth hormone control of the liver microsomal low-affinity glucocorticoid binding site (LAGS). J Steroid Biochem Mol Biol 1997; 63: 219 28.
  • 7
    Janssen JA, Stolk RP, Pols HA, Grobbee DE, De Jong FH, Lamberts SW. Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrinol 1998; 48: 471 78.
  • 8
    Edén Engström B, Karlsson FA, Wide L. Marked gender differences in ambulatory morning growth hormone values in young adults. Clin Chem 1998; 44: 1289 95.
  • 9
    Friedewald WT, Levy RI, Fredricksson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499 502.
  • 10
    Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Hoffman AR. The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Horm Metab Res 1994; 26: 229 33.
  • 11
    Vahl N, Møller N, Lauritzen T, Christiansen JS, Jørgensen JOL. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. J Clin Endocrinol Metab 1997; 82: 3612 18.
  • 12
    Møller N, Schmitz O, Porksen O, Møller J, Jørgensen JO. Dose–response studies on the metabolic effects of a growth hormone pulse in humans. Metabolism 1992; 41: 172 75.
  • 13
    Møller N, Jørgensen JO, Schmitz O et al. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 1990; 258: 86 91.
  • 14
    Møller N, Butler PC, Antsiferov MA, Alberti KG. Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 1989; 32: 105 10.
  • 15
    Edén Engström B, Karlsson FA, Wide L. Gender differences in diurnal growth hormone and epinephrine values in young adults during ambulation. Clin Chem 1999; 45: 1235 39.
  • 16
    Johannsson G, Oscarsson J, Rosén T et al. Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Arterioscler Thromb Vasc Biol 1995; 15: 2142 50.
  • 17
    Binnerts AR, Swart G, Wilson JHP. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocr 1992; 37: 79 87.
  • 18
    Friedman M, Byers SO, Rosenman RH, Li CH, Neuman R. Effects of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects. Metabolism 1974; 23: 905 12.
  • 19
    Møller A, Rasmussen LM, Thuesen L, Christiansen JC. Impact of human growth hormone on plasma lipoprotein concentrations. Horm Met Res 1989; 21: 207 9.
  • 20
    Björntorp P. Hormonal control of regional fat distribution. Hum Reprod 1979; 12: 21 25.
  • 21
    Ottosson M, Wikman-Adolfsson K, Enerbäck S, Elander A, Björntorp P, Edén S. Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1995; 80: 936 41.
  • 22
    Jensen MD & Levine J. Effects of oral contraceptives on free fatty acid metabolism in women. Metabolism 1998; 47: 280 84.
  • 23
    Nasr A & Brechwoldt M. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol 1998; 12: 43 59.
  • 24
    Speroff L, Rowan J, Symons J, Genant H, Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial. J Am Med Asspc 1996; 276: 1397 403.
  • 25
    O’Brien T & Nguyen TT. Lipids and lipoproteins in women. Mayo Clin Proc 1997; 72: 235 44.
  • 26
    Volpe A, Amram A, Cagnacci A, Battaglia C. Biochemical aspects of hormonal contraception: effects on bone metabolism. Eur J Contracept Reprod Health Care 1997; 2: 123 26.
  • 27
    Volpe A, Malmusi S, Zanni AL, Landi S, Cagnacci A. Oral contraceptives and bone metabolism. Eur J Contracept Reprod Health Care 1997; 2: 225 28.
  • 28
    Corson SL. Oral contraceptives for the prevention of osteoporosis. J Reprod Med 1993; 38: 1015 20.
  • 29
    DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 1996; 174: 15 20.
  • 30
    Holloway L, Butterfield G, Hints RL, Gesundheit N, Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab 1994; 79: 470 79.
  • 31
    Clemmons DR, Underwood LE, Ridgay EC, Kliman B, Kjellberg RN, Van Wyk JJ. Estradiol treatment of acromegaly: reduction of immuno-reactive somatomedin C and improvement of metabolic status. Am J Med 1980; 69: 571 75.
  • 32
    Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab 1996; 81: 2848 53.
  • 33
    Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thorner MO. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women – a clinical research center study. J Clin Endocrinol Metab 1996; 81: 2250 56.
  • 34
    Veldhuis JD. Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol 1996; 134: 287 95.
  • 35
    Kelly JJ, Rajkovic IA, O’Sullivan AJ, Sernia C, Ho KKY. Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol 1993; 39: 561 67.
  • 36
    Weissberger AJ, Ho KK, Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 1991; 72: 374 81.
  • 37
    Campagnoli C, Biglia N, Cantamessa C, Di Sario MM, Lesca L. Effects of progestins on IGF-I serum level in estrogen-treated postmenopausal women. Zentralbl Gynakol 1997; 119: 7 11.
  • 38
    Campagnioli C, Biglia N, Altare F et al. Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol 1993; 7: 251 58.
  • 39
    Blok GJ, De Boer H, Gooren LJG, Van Der Veen EA. Growth hormone substitution in adult growth hormone-deficient men augments androgen effects on the skin. Clin Endocrinol 1997; 47: 29 36.
  • 40
    Zachmann M & Prader A. Anabolic and androgenic effect of testosterone in sexually immature boys and its dependency on growth hormone. J Clin Endocrinol Metab 1970; 30: 85 95.
  • 41
    Yang S, Xu X, Björntorp P, Edén S. Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats. J Endocrinol 1995; 147: 147 52.
  • 42
    Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obesity 1996; 20: 291 302.